Thursday, March 26, 2026 11:50:02 AM
Did they hired Dstock/Danish Dude to write this part? See ->
NICE reimbursement negotiations will easily take 2-3 years from MHRA decision. Not 1 year or less.
first commercial launch in the UK later in 2027... (read 2028 for real life) but lets say it is late 2027, well this mean there is another year of dilution minimum. And without NICE reimbursment, well another 2-3 years...
Hopefully this overly optimistic report open the eyes of many. We all got scammed. By the likes of friends/acquintances who believed idiot/scam artist like (we all know their usernames).
followed by pricing and
reimbursement negotiations with NICE through 2026 and early 2027, and a
first commercial launch in the UK later in 2027
NICE reimbursement negotiations will easily take 2-3 years from MHRA decision. Not 1 year or less.
first commercial launch in the UK later in 2027... (read 2028 for real life) but lets say it is late 2027, well this mean there is another year of dilution minimum. And without NICE reimbursment, well another 2-3 years...
Hopefully this overly optimistic report open the eyes of many. We all got scammed. By the likes of friends/acquintances who believed idiot/scam artist like (we all know their usernames).
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
